Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of antineoplaston therapy for malignant brain tumors has completed and posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer

Drugs mentioned

• Antineoplaston A-10 (antineoplaston A-10)
• Antineoplaston AS2-1 (AS2-1)

Snippet

Sponsor: Burzynski Research Institute | Conditions: Malignant Brain Tumors | Phase 2 | Status: COMPLETED | Results posted: 2016-12-19